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Introduction: National chronic dialysis 
data have had impact in the treatment 
planning. Objective: To report data of 
the annual survey of the Brazilian Society 
of Nephrology about chronic kidney 
disease patients on dialysis in July 2013 
and compare with 2011-12. Methods: A 
survey based on data of dialysis units 
from the whole country. The data 
collection was performed by using a 
questionnaire filled out on-line by the 
dialysis units. Results: Three hundred 
thirty four (51%) of the dialysis units in 
the country answered the questionnaire. 
In July 2013, the total estimated number 
of patients on dialysis was 100,397. The 
estimated prevalence and incidence rates 
of chronic maintenance dialysis were 
449 (range: 284 in the North region 
and 622 in the South) and 170 patients 
per million population, respectively. 
The estimated number of new patients 
starting dialysis in 2013 was 34,161. 
The annual gross mortality rate was 
17.9%. For prevalent patients, 31.4% 
were aged 65 years or older, 90.8% were 
on hemodialysis and 9.2% on peritoneal 
dialysis, 31,351 (31.2%) were on a 
waiting list of renal transplant, 30% 
were diabetics, 17% had PTH levels > 
600 pg/ml and 23% hemoglobin < 10 g/
dl. A venous catheter was the vascular 
access for 15.4% of the hemodialysis 
patients. Conclusion: The absolute 
number of patients on dialysis has 
increased 3% per year. The prevalence 
and incidence rates of patients on 
dialysis leveled off, while the mortality 
rate tended to decrease compared with 
2012. There was a trend towards a 
better control of the anemia and PTH 
levels.
AbstrAct
Keywords: epidemiology; renal dialysis; 
renal insufficiency, chronic; survival.
IntroductIon
The national survey organized by 
the Brazilian Society of Nephrology 
(SBN) has been carried out for over 
10 years to collect basic information 
from dialysis patients with chronic 
kidney disease treated in centers 
registered with the SBN. Patient 
information has been collected 
online for the past five years, in a 
change that significantly facilitated 
the implementation of survey 
procedures in Brazil, a country 
of continental size, with over 660 
dialysis centers in 2013. The survey 
has been designed mainly to gather 
basic epidemiological and technical 
data to further the knowledge on 
patients and dialysis centers and 
provide input for conversations 
with the Government and health 
care providers on how to improve 
quality of care. This initiative has 
relied on the voluntary participation 
of a significant portion of dialysis 
centers in the country. In addition to 
characterizing patients on chronic 
dialysis on July 1, 2013, this report 
also offers comparisons and remarks 
on the trends observed between 
2011 and 2013 and long-term data 
on the incidence and prevalence of 
treatment.
Methods
A survey was carried out in the 
second half of 2013 with chronic 
kidney disease patients on dialysis 
treated at centers registered with the 
DOI: 10.5935/0101-2800.20140068
J Bras Nefrol 2014;36(4):476-481
2013 Brazilian Dialysis Survey
477
SBN. A questionnaire was made available on 
the SBN website from August to November 
of 2013, and registered dialysis centers were 
informed in written and asked to submit 
their responses online to the Secretary of the 
Society. Centers failing to send their answers 
were reminded to do so monthly until the 
final date set for submissions (November 30, 
2013). When necessary, data were obtained 
or confirmed over the phone in interviews 
with the Secretary of the SBN. The questions 
on most sociodemographic, clinical, workup 
and treatment aspects referred to patients on 
dialysis on July 1, 2013. Data on mortality and 
entry of new patients on dialysis comprised the 
whole month of July of 2013 and estimates for 
the entire year.
Six hundred and fifty-eight of 703 dialysis 
centers registered with the SBN in July of 2013 
had active chronic dialysis programs, and 334 
(50.8%) completed the questionnaire and 
had their data analyzed. Data from 50,961 
patients on dialysis from 334 participating 
centers were included. Patient data sets 
were pooled together, rather than being kept 
separately for each individual. Therefore, they 
are to be interpreted as a representation of the 
more prevalent treatment practices offered to 
patients seen at each dialysis center. National 
data were estimated taking into account the 
numbers expected of centers that did not join 
the survey based on their regional locations. 
Non-respondents were assigned the mean 
number of patients observed in their region, 
and their totals were computed in the estimates.
The national and regional population 
estimates used in the calculations of prevalence 
and incidence derived from the updated 
estimates published by the Brazilian Institute 
of Geography and Statistics (IBGE) for July of 
2013. Pooled data were used to estimate the 
percentage of patients outside recommended 
target indicators1,2 for dialysis dosage (Kt/V or 
urea reduction ratio) and serum concentrations 
of albumin, phosphorus, PTH and hemoglobin. 
Most data were shown in a descriptive fashion 
for the year of 2013, and in comparisons to 
20113 and 2012.4
calculatiOns used in estimatiOn
Estimated total N of patients on July 1: N 
of patients obtained in the sample/ratio of 
active respondent centers. Estimated global 
prevalence rate: Estimated total N of patients 
on July 1/Brazilian population on July 1, 
2013, expressed as per million population. 
Only the data pertaining to each region of 
the country were considered in the estimation 
of the regional N and ratio values. Estimated 
total N of patients starting dialysis in 2013: N 
of patients informed to have started treatment 
in July x 12/ratio of active respondent centers. 
Estimated global incidence rate: estimated 
total N of patients starting treatment in 
2013/Brazilian population on July 1, 2013, 
expressed as per million population. Prevalence 
related to demographic, clinical, workup, and 
medication data were expressed in relation 
to the responses given for each of the aspects 
considered for 50,961 patients enrolled from 
334 respondent clinics. Total N of deaths 
estimated in 2013: N of deaths reported in July 
x 12/ratio of active respondent centers. Gross 
mortality rate: estimated total N of deaths in 
2013/estimated N of patients on dialysis on 
July 1, 2013.
results
The total number of active centers in 2013 
increased slightly when compared to 2012-
11 (658, 651 and 643, respectively). The 
active centers responding to the survey were 
distributed as follows: 28% were located in 
the South of Brazil, 40% in the Southeast, 
9% in the Midwest, 17% in the Northeast, 
and 6% in the North. Fifty-one percent of the 
active dialysis centers answered the survey 
questionnaire (n = 334/658). The participation 
of dialysis centers in the survey varied by 
region. Participation was higher in the South 
and North regions (68% and 59%) and lower 
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in the Southeast and Midwest regions (43% 
and 45%, respectively). The questionnaires 
answered by the 334 centers comprised the 
data of 50,961 patients. Eighty-four percent of 
these patients had public health insurance and 
16% were covered by private health insurance. 
The dialysis centers included in the survey had 
an occupancy rate of 85%. Fifty-one percent of 
them were located inside a hospital. Seventy-
three percent of the centers catered to patients 
with chronic kidney disease on conservative 
treatment and 67% took care of individuals 
with acute kidney injury. The centers included 
in the study had one nephrologist per 28 
patients on dialysis.
An estimated 100,397 patients were on 
dialysis in Brazil on July 1, 2013. This number 
has gradually increased over the years: 97,586 
in 2012; 91,314 in 2011; and 54,523 in 2003. 
A mean annual increase of three percent on the 
number of patients has been observed within 
the last three years. Half of these patients were 
treated in Southeastern Brazil. The prevalence 
rate of dialysis in 2013 was 499 patients per 
million population (pmp), varying by region 
from 284 patients pmp in the North to 622 
patients pmp in the South (Figure 1). The 
global dialysis prevalence rate was unchanged 
when compared to 2012 (503 pmp), despite the 
six-percent growth seen from 2011 (475 pmp) 
to 2012. An estimated 34,161 patients were 
started on dialysis in 2013, the equivalent to an 
incidence rate of 170 patients pmp (Figure 2). 
The estimated incidence rate in 2012 and 2011 
was 177 and 149 patients pmp, respectively. 
Fifty-five percent of the patients (n = 18,700) 
started dialysis in the Southeast, 6,019 in the 
Northeast, 5,249 in the South, 3,608 in the 
Midwest, and 1,668 in the North region. The 
annual incidence rate of dialysis ranged from 
98 pmp in the North region to 241 pmp in 
the Midwest (Figure 2). The estimated number 
of new patients starting dialysis was similar to 
the number observed in 2012 (n = 34,366) and 
higher than in 2011 (n = 26,680).
Fifty-eight percent of the patients were 
males. The percentage of patients on dialysis 
Figure 1. Estimated prevalence of patients on dialysis in Brazil per 
region, 2011-2013.
Figure 2. Estimated incidence of patients on dialysis in Brazil per 
region, 2011-2013.
aged 12 years and under, 13-18 years, 19-64 
years, 65-80 years, and 80 and older was 0.4%, 
5.6%, 62.6%, 26.7% and 4.7%, respectively. 
The percentage of patients aged 18 years and 
under grew substantially from 2011 (1.6% 
aged ≤ 18 years), while the percentage of 
elderly individuals remained unaltered (31.5% 
≥ 65 years in 2011). In July of 2013, 90.8% of 
the patients on chronic dialysis were offered 
hemodialysis and 9.2% were on peritoneal 
dialysis. Most patients on peritoneal dialysis 
were offered automated peritoneal dialysis 
(APD). Table 1 shows the distribution of 
patients according to the type of dialysis and 
health insurance type; a significantly higher 
percentage of patients on private health 
insurance were on daily hemodialysis or 
peritoneal dialysis, particularly APD, when 
compared to individuals on public health 
insurance. Peritoneal dialysis was offered 
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Conventional 
HD





150 (0.3) 388 (4.8) 538 (1.1)
CAPD 1,580 (3.7) 197 (2.5) 1,777 (3.5)
APD 2,124 (4.9) 728 (9.1) 2,852 (5.6)
DPI 62 (0.1) 7 (0.1) 69 (0.1)
Total 42,934 (100) 8,027 (100) 50,961 (100)
tAble 1 distributiOn Of patients per type Of dialysis 
 and health insurance, 2013 census
Figure 3. Percent of patients with workup results outside the levels 
recommended in international guidelines, 2011-13.
to 8.7% of the patients on the public health 
insurance and to 11.7% of the patients on 
private health insurance.
In 2013, the most common causes of kidney 
disease were hypertension (35%) and diabetes 
(30%), followed by chronic glomerulonephritis 
(12%) and polycystic kidney disease (4%); 
12% of the patients were diagnosed with 
kidney disease for other causes, and undefined 
causes accounted for eight percent of the 
cases. There was no significant change in these 
percentages over the last three years.
The prevalence of positive serology for 
hepatitis C and B in patients on dialysis in 
Brazil was 4.2% and 1.4%, respectively, 
whereas 0.7% had HIV. In 2012 and 2011, the 
prevalence of positive serology for hepatitis C, 
B, and HIV was 4.6% and 5.5%; 1.0% and 
1.1%; and 0.8% and 0.8%, respectively.
The estimated percentage of patients on 
hemodialysis with a central venous catheter 
was 15.4% (short residence catheter: 9.4%, 
indwelling permcath: 6.0%), while 3.3% had 
vascular grafts. In the sample assessed in July 
of 2013, the monthly hospitalization rate was 
5.8%, against 5.7% and 6.1% in 2012 and 2013, 
respectively. Figure 3 shows that, in reference 
to recommended workup levels,1,2 19% of the 
patients on dialysis had a Kt/V < 1.2 or a urea 
reduction ratio < 65%, 15% had serum albumin 
levels < 3.5 g/dL, 36% had serum phosphorus > 
5.5 mg/dL, 17% had PTH values greater than 
600 pg/ml, and 15% had levels below 100 pg/ml. 
Thirty-three percent had hemoglobin levels < 11 
g/dl and 23% had values under 10 g/dL. A trend 
was observed of better management of PTH and 
hemoglobin levels.
Figure 4 shows the distribution of medi-
cations used by the patients: 79% were on 
erythropoietin, 53% on intravenous iron, 
31% on calcitriol, 2% on paricalcitol, 2% on 
cinacalcet, and 38% on sevelamer.
An estimated 31,351 patients were registered 
on the waiting list for transplantation in July 
2013, or 31.2% of the individuals then on dialy-
sis (n = 32,454 in 2011; n = 30,447 in 2012).
In 2013, an estimated 17,944 patients on 
dialysis died, corresponding to a gross death rate 
(with the dialysis population on July 1 in the de-
nominator) of 17.9% for the year. This rate has 
decreased in recent years (Figure 5).
dIscussIon
The 2013 survey had the participation of 51% 
of the active dialysis centers in the country, a 
number greater than in 2012 and slightly lower 
than in 2011 (39% and 55%, respectively).3.4 
A substantial share of the active centers was 
represented, despite the voluntary nature of 
their participation. Although the distribution 
of participating centers mirrored the regional 
distribution of dialysis centers in Brazil, 
more centers located in the South and North 
regions (68% and 59% of active centers) 
joined the survey when compared to centers 
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South to this report. In recent years, reports from 
the United States and other developed European 
and Asian countries have alluded to increases 
in prevalence rates, although the incidence rate 
of patients on renal replacement therapy has 
increased discreetly or displayed a tendency to 
flattening out.5 For example, prevalence rates in 
the United States increased by approximately 3% 
a year in the 2007-2011 period.5
The global prevalence rate of dialysis 
(499/pmp) must be added to the prevalence rate 
of patients with functioning renal grafts (200/
pmp) to yield the actual rate of individuals on 
renal replacement therapy, which should be at 
700/pmp or thereabouts. This latter rate is lower 
than what was observed in countries such as Chile 
(1230/pmp), Argentina (800/pmp) and some 
European (900-1000/pmp) and North American 
nations (1920/pmp) in 2011.4 However, given the 
large regional differences in Brazil, the rates seen 
in the Southeast and South regions, for example, 
are probably greater than 800/pmp and closer 
to the reality of developed nations. Similarly to 
2012, approximately 34,000 patients (170/pmp) 
were started on chronic dialysis treatment in 
2013. As observed in prevalence rates, regional 
variations in incidence rates varied between 100 
and 240 pmp. The actual incidence rate can be 
obtained by including the recipients of preemptive 
transplants in the calculation. The yielded global 
incidence rate is similar to the rates observed in 
many European countries, although well below 
the rates seen in the United States (362/pmp) and 
Japan (295/pmp).4
An intriguingly high portion of children 
and adolescents were on dialysis in 2013 when 
compared to 2012 and 2011 (6.0%, 4.5%, and 
1.6%, respectively). This finding may need 
confirmation. The data collection procedure 
utilized may have led to discrepancies in 
the numbers of this subgroup, and there are 
no apparent reasons for such an increase to 
have occurred within the last two years. The 
relative number of patients on maintenance 
hemodialysis - 90.2% - has remained unchanged 
when compared to previous years. APD 
and daily hemodialysis rates have remained 
consistently higher among patients on private 
health insurance, although individuals on 
Figure 4. Percent of patients using selected medications, 2011-13.
Figure 5. Annual gross mortality rate of patients on dialysis, 2011-2013.
located in the Southeast and Midwest regions 
(43% and 45%, respectively), which may 
have impacted the representativeness of the 
results. The best way to interpret our data is 
by observing the trends from previous years, 
as done in this report. The estimates pointed 
out to a stabilization in incidence rates and a 
continued increase in the absolute number of 
patients on treatment, although the prevalence 
of patients on dialysis remained flat in 2013 
when compared to 2012. In the 2010-2013 
period, the number of patients on dialysis 
increased by a mean of 3% a year.
Our annual estimates must be interpreted 
with caution due to the percent participation of 
dialysis centers and the need to further validate 
the survey questionnaire. Wide variations have 
been reported in the prevalence and incidence 
rates submitted by each region of the country. 
This particular year, prevalence was higher in 
the South, tended toward stabilization in the 
Southeast, and was lower in the Northeast region, 
which may have been partly influenced by the 
greater contribution of the centers located in the 
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daily hemodialysis account for only 1% of all 
dialysis patients. The share of patients using 
venous catheters increased slightly (15.4% 
in 2013 vs. 14.5% in 2012) and, for the first 
time, the number of patients using indwelling 
(with subcutaneous tunnel) and short 
residence catheters (6% and 9.4% of the total, 
respectively) was estimated; vascular grafts 
were used by 3.4% of the patients.
Hypertensive nephropathy (35%) and 
diabetes (30%) were the main underlying 
diseases seen in patients on dialysis. Positive 
serology for hepatitis C kept on decreasing, 
while the number of patients with hepatitis 
B increased slightly. The percentage of HIV-
positive patients remained unaltered. The 
number of patients with workup results outside 
the levels recommended in international 
guidelines revealed a trend toward reduction, as 
the percentage of individuals with hemoglobin < 
11 g/dl dropped from 39% in 2011 to 33% in 
2013. Reductions were also seen in the number 
of patients with hemoglobin levels below 10 g/
dl (25% in 2012 vs. 23% in 2013), thus meeting 
the currently advocated target. The number of 
patients on erythropoietin and intravenous iron 
has remained high and unaltered.
The latest survey findings revealed that 
fewer patients had very high or very low PTH 
levels, which may reflect the better quality of 
medical care provided to individuals treated for 
hyperparathyroidism and the greater availability of 
other medications in recent years (paricalcitol and 
cinacalcet). A high number of patients with anemia 
and high phosphorus and PTH levels in relation 
to guideline recommendations has also been 
observed in European nations, the United States 
and Japan.6,7 A significant portion of the patients 
had poor performance in workup indicators for 
mineral metabolism disorders (phosphorus and 
PTH), although a great deal of them had been on 
medications such as sevelamer (38%) and vitamin 
D (calcitriol - 31%), and some had been recently 
started on paricalcitol and cinacalcet. The latter 
two medications are currently not offered by the 
Brazilian public health care authority, as opposed 
to calcitriol and sevelamer. As their use increases, 
the management of hyperparathyroidism will be 
potentially improved. The gross mortality rate 
decreased in relation to 2011 (17.9% vs. 19.9%), 
possibly due to improvements on treatment 
efficacy. The number of elderly individuals and 
patients with diabetic nephropathy remained 
unchanged, revealing that these factors were not 
associated with greater risk of death. The gross 
mortality rate for patients on dialysis in Brazil 
remains below the level described for the North 
American patient population.5
Generalizations from this study should be 
made with caution, due to the voluntary nature of 
participation in the survey, the way in which data 
were collected for patient groups in each center, 
and the need to validate survey responses.
conclusIons
The survey revealed the number of patients on 
dialysis is trending up, although the incidence 
and prevalence of dialysis has remained stable. 
Mortality rate, by its turn, is trending down. 
Disorders such as anemia and hyperparathyroidism 
are apparently being better managed, although 
this finding requires confirmation. This survey has 
offered valuable information for the improvement 
of the care provided to patients with advanced 
chronic kidney disease and the enhancement of 
the national policies for dialysis in Brazil.
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